Genentech, Inc.

South San Francisco, CA ManufacturingNAICS 325410

Self-funded health planPlan year 2025Renews January
21,651Participants-7% vs. prior year
$51.3MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#1 of 61Manufacturing in CABy participants

Overview

Genentech, Inc. sponsors a self-funded health plan that covered 21,651 participants in plan year 2025, down 7% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
21,651 · prior year 23,283
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
U.S. Roche Health and Welfare Benefits Veba Plan, plan 512 (21,651 participants)
Broker compensation
$313K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityPrepaid legalLong-term disabilitySeveranceDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Kaiser Foundation Health Plans Inc.HMO5,412$47.4M—
Continental American Insurance CompanyLife21,629$13.5M$313K
Kaiser Foundation Health Plan of the NorthwestHMO, Medical, Prescription drug511$3.1M—
Metropolitan General Insurance CompanyLegal7,931$1.9M—

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$51.3M/ year

Estimated prescription spend: 21,651 participants × $2,371 national average per member. Usually higher once dependents are counted.

$1.3M–$3.3M/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$390K–$975K
Lower-cost therapeutic alternatives$570K–$1.2M
Generic pricing vs. actual cost$246K–$739K
PBM contract terms$128K–$385K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Genentech, Inc.
Sponsor EIN
94-2347624
Plan number
512
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 94-2347624 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
U.S. Roche 401(k) Savings Plan
Type
401(k) plan
Participants
36,458

About this data

Source: Genentech, Inc.'s Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Genentech, Inc..

Request a correction · Methodology